SNMMI @SNM_MI Twitter profile

Last Seen Profiles

@Ururi_Rapis

@wdbayouth

@DestinyVaushCEO

@kuwawomote

@pZnQ9aZ3Q61JtMp

@euronewsnext

@oocfintwit

@KITHOnline

@miyuki161768864

@P0oWmmopnhNK78V

@MountCarmelHS

@heavenlymotherr

@dicked_grayson

@Dustinlynchmsc_

@lL5pfU7iPHh3Fo4

@thedongmint

@AlexVita9

@TransPantyBulge

@TvesSonrie

@BBescty

@JorgeMCesar

@CoachKade_Glenn

@simkjrs

@ria_arts_

@mattRlive

@reddskyy_

@NagasakiPengin

@Gerhardhormann

@sammisilber

@NAYouthCenter

@GameDayUSA

@CollaVerglas

@hijabjilbab1

@chartrdaily

@BackendWan

@yuko_logic

SNMMI

@SNM_MI

5 years

A new radiotracer can identify nearly 30 types of cancer, according to research featured in the June issue of The Journal of Nuclear Medicine. The tracer has potential for treating cancer in the future. #Cancer #PrecisionMedicine #NuclearMedicine

1

78

123

SNMMI

@SNM_MI

11 months

SNMMI 2023 Image of the Year: New theranostic pair facilitates early detection and effective treatment of #PancreaticCancer . Congratulations to Julie Sutcliffe, PhD, and colleagues! #SNMMI23 #MedicalResearch

1

46

120

SNMMI

@SNM_MI

3 years

Big news: Today the FDA approved 18F-DCFPyL, a new imaging agent for diagnosis of prostate cancer, providing a more effective imaging approach for detecting metastasis or recurrence. #ProstateCancer #MedicalImaging #PETimaging #PSMA

1

38

113

SNMMI

@SNM_MI

4 years

Molecular imaging pioneer Sanjiv “Sam” Gambhir, MD, PhD, passed away on Saturday, July 18. He was a brilliant researcher and a wonderful human being. #NuclearMedicine

1

23

97

SNMMI

@SNM_MI

11 months

Peter J. H. Scott, PhD, has been named as the 2023 recipient of the SNMMI Sam Gambhir Trailblazer Award. Congratulations on this honor! #SNMMI23 #NuclearMedicine

5

12

88

SNMMI

@SNM_MI

2 years

SNMMI 2022 Image of the Year: Predicting Remodeling and Outcome from Molecular Imaging of Fibroblast Activation in Patients after Acute Myocardial Infarction. Congratulations! #SNMMI22 #PETimaging #MedicalResearch

3

41

86

SNMMI

@SNM_MI

3 years

SNMMI 2021 Image of the Year: PET Imaging Measures Cognitive Impairment in COVID-19 Patients. Congratulations! #SNMMI21 #COVID19 #PETimaging #MedicalResearch

0

35

76

SNMMI

@SNM_MI

2 years

Andrei Iagaru, MD, FACNM, has been named as the first recipient of the SNMMI Sam Gambhir Trailblazer Award. Congratulations on this honor! #SNMMI22 #NuclearMedicine

1

12

77

SNMMI

@SNM_MI

5 years

SNMMI’s Image of the Year award goes to an image showcasing the efficacy of the FAPI radiotracer, which allows for new applications in noninvasive diagnosis, staging and treatment. #cancer #MedicalResearch #NuclearMedicine #SNMMI19

0

41

71

SNMMI

@SNM_MI

6 years

#SNMMI18 - SNMMI Image of the Year: PSMA PET Imaging of Theranostic for Advanced Prostate Cancer. #ProstateCancer #theranostic

2

60

72

SNMMI

@SNM_MI

2 years

SNMMI applauds today’s FDA approval of a new, game-changing #NuclearMedicine treatment for metastatic #ProstateCancer shown to reduce risk of death by 38% and risk of progression by 60% in #mCRPC patients. #PrecisionMedicine #RadiopharmaceuticalTherapy

2

41

68

SNMMI

@SNM_MI

11 months

Congratulations are in order for Henry VanBrocklin, PhD, FSNMMI, FSRS, the 2023 recipient of the prestigious SNMMI Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science. #SNMMI23 #NuclearMedicine

2

11

67

SNMMI

@SNM_MI

4 years

The FDA has approved a new process for producing Ga-68 DOTATOC, which localizes neuroendocrine tumors in adult and pediatric patients. The process uses cyclotron-produced Ga-68, which will allow for higher-volume production. #NuclearMedicine #NETCancer

0

28

62

SNMMI

@SNM_MI

11 months

That’s a wrap on the SNMMI 2023 Annual Meeting. Thanks to all who attended; see you in Toronto in 2024! #SNMMI23

0

7

62

SNMMI

@SNM_MI

4 years

SNMMI 2020 Image of the Year: Super-Agers Show Resistance to Tau and Amyloid Accumulation; Maintain High Cognitive Function. Congratulations! #SNMMI20 #Alzheimers #MedicalImaging

0

18

60

SNMMI

@SNM_MI

2 years

New PSMA PET research has validated the EAU classification system to determine risk of prostate cancer recurrence, according to The Journal of Nuclear Medicine. #NuclearMedicine #ProstateCancer #PrecisionMedicine

0

28

62

SNMMI

@SNM_MI

2 years

Ultra-low dose total-body PET/CT effective for evaluating #arthritis , according to new research from @JournalofNucMed . #MedicalImaging #PETCT #JNuclMed

0

17

61

SNMMI

@SNM_MI

3 years

New York Times covers the success of Lu-177 PSMA-617 for #ProstateCancer in today’s Health section. @JournalofNucMed : “PSMA-targeted #theranostics is … among the greatest success stories in the history of #NuclearMedicine .” #NucMed #Cancer #PSMA

New Therapy for Aggressive Prostate Cancer Improves Survival (Published 2021)

The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.

www.nytimes.com

2

30

59

SNMMI

@SNM_MI

11 months

New Guideline Alert! Joint #SNMMI #EANM guideline for Lu-177 PSMA-targeted therapy will help practitioners select high-potential patients and prepare for clinical management. Thanks @EANM_NucMed ! #NuclearMedicine #RPTherapy #ProstateCancer

0

24

52

SNMMI

@SNM_MI

6 months

Bone scans overstage prostate cancer at initial staging compared with PSMA PET, according to new research published in @JournalofNucMed . #NuclearMedicine #ProstateCancer #PETscan

0

21

51

SNMMI

@SNM_MI

1 year

#SNMMI celebrates World Theranostics Day 2023 in honor of Dr. Saul Hertz! Get the latest radiopharmaceutical therapy updates from SNMMI and around the world at the SNMMI Radiopharmaceutical Therapy Central:

0

26

51

SNMMI

@SNM_MI

1 month

#SNMMI celebrates World Theranostics Day 2024 in honor of Dr. Saul Hertz! Get the latest radiopharmaceutical therapy updates from SNMMI and around the world at the SNMMI Radiopharmaceutical Therapy Central: 52w

0

23

51

SNMMI

@SNM_MI

3 years

FDA makes history with approval of Ga-68 PSMA-11 PET via @AuntMinnie

FDA makes history with approval of Ga-68 PSMA-11 PET

The U.S. Food and Drug Administration's (FDA) recent approval of a PET radiotracer that targets lesions positive for prostate-specific membrane antigen (PSMA) is not only a "quantum leap" for the...

www.auntminnie.com

1

17

49

SNMMI

@SNM_MI

4 years

Congratulations to Carolyn J. Anderson, PhD, the 2020 recipient of the prestigious SNMMI Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science. #SNMMI20 #NuclearMedicine

3

9

49

SNMMI

@SNM_MI

2 years

Congratulations to Simon Cherry, PhD, recipient of the 2022 Benedict Cassen Prize for Research. Dr. Cherry presented the Cassen Lectureship on “A Matter of Time” during a special plenary session this morning. #SNMMI22

2

9

50

SNMMI

@SNM_MI

9 months

SNMMI is pleased to announce our annual list of early career professionals selected as “Ones to Watch” in 2023. We are proud to showcase rising talent in the field, offering a platform to increase recognition for early career professionals within our specialty. Congratulations!

5

7

47

SNMMI

@SNM_MI

11 months

Congrats to SNMMI’s newly inducted Fellows! Thank you for your service to the society and the field. #SNMMI23

0

7

48

SNMMI

@SNM_MI

1 year

Novartis has received FDA approval to supply Pluvicto from its Millburn, NJ, plant, with plans to ramp up production in the coming weeks. SNMMI will share more information as it becomes available. #NuclearMedicine #RPTherapy #ProstateCancer

1

15

47

SNMMI

@SNM_MI

3 years

A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted therapies for cancer patients, according to research published in @JournalofNucMed . #PrecisionMedicine #Theranostics #Cancer

0

27

47

SNMMI

@SNM_MI

4 years

A novel nuclear medicine radiotracer could help identify the extent of metastatic prostate cancer and select patients for therapy. #ProstateCancer #PrecisionMedicine #NuclearMedicine

0

29

48

SNMMI

@SNM_MI

7 months

Breaking News: The FDA has approved the imaging agent Technegas for use in ventilation–perfusion (V/Q) studies to diagnose respiratory disease. #NuclearMedicine #LungDisease

2

20

47

SNMMI

@SNM_MI

4 years

A new radiopharmaceutical, 68Ga-DOTA-JR11, shows excellent imaging performance for neuroendocrine cancer patients with liver metastases, providing important information to guide treatment. #NeuroendocrineCancer #MedicalImaging #NuclearMedicine #JNM

0

27

47

SNMMI

@SNM_MI

3 years

A new PET tracer that targets inflammation is safe and can clearly identify early stages of #rheumatoid #arthritis , according to research in @JournalofNucMed . #MedicalImaging #PETCT #RA #JNM

0

14

48

SNMMI

@SNM_MI

6 months

This year, the tracer principle - a key concept within nuclear medicine, molecular imaging, and radiotheranostics - turns 100 years old. #NuclearMedicine #Theranostics #MolecularImaging @DrAGafita @radnucmp @SHoberueck

0

17

46

SNMMI

@SNM_MI

8 months

A new imaging agent, ⁶⁸Ga-ABY-025, can predict early metabolic response to HER2-targeted treatment in HER2-positive metastatic #BreastCancer patients, according to new research published in JNM. #NuclearMedicine #MedicalImaging @JournalofNucMed

0

17

45

SNMMI

@SNM_MI

4 years

ANNOUNCEMENT: Today SNMMI President Vasken Dilsizian, MD, unveiled the re-imagined SNMMI 2020 Annual Meeting—Virtual Edition! This virtual experience, on July 11-14, will be FREE to SNMMI members, discounted for nonmembers. #SNMMI20 #NuclearMedicine

2

31

45

SNMMI

@SNM_MI

1 year

SNMMI announces list of early career professionals selected as “Ones to Watch” in 2022. We are proud to showcase rising talent in the field, offering a platform to increase recognition for early career professionals within our specialty. Congratulations to our 2022 honorees!

4

8

45

SNMMI

@SNM_MI

2 years

The Journal of Nuclear Medicine impact factor rose to 11.082, the highest in its history and fourth among all medical imaging journals worldwide, according to new data just released in the 2021 Journal Citation Reports. #NuclearMedicine #MedicalImaging

1

11

46

SNMMI

@SNM_MI

2 years

#SNMMI celebrates World Theranostics Day 2022 in honor of Dr. Saul Hertz! Get the latest radiopharmaceutical therapy updates from SNMMI and around the world at The Therapy Center of Excellence and recent articles in The Journal of Nuclear Medicine (JNM),

0

25

45

SNMMI

@SNM_MI

5 years

A new nuclear medicine method for detecting malignant melanoma has been successfully tested for the first time in humans and could improve detection of both primary and metastatic melanoma. #PETimaging #melanoma #skincancer

1

33

42

SNMMI

@SNM_MI

2 years

TerraPower, a nuclear innovation company founded by Bill Gates, announced $750 million funding raised to enhance the company’s “groundbreaking work in advanced nuclear energy technologies and nuclear medicine.” #NuclearMedicine #Cancer

0

14

43

SNMMI

@SNM_MI

5 years

The EXPLORER total-body PET scanner is the first medical imaging scanner of any kind that can capture 3D images of the entire human body at the same time. Case studies show many benefits and possibilities. #PETCT #MedicalResearch #PrecisionMedicine

0

26

42

SNMMI

@SNM_MI

3 years

It’s Nuclear Medicine & Molecular Imaging Week—the time to celebrate you & your colleagues! Thank you for all you do to advance precision medicine & elevate the profession. Tell us how you’re celebrating. Tag #NucMed21 & #SNMMI in your social media posts!

2

22

43

SNMMI

@SNM_MI

1 year

Amino acid PET successfully differentiates recurrent brain metastases, reducing invasive procedures and overtreatment, according to @JournalofNucMed #NuclearMedicine #MolecularImaging #BrainCancer #JNuclMed

0

22

41

SNMMI

@SNM_MI

4 years

SNMMI is pleased to announce our annual list of 30 early career professionals selected as “Ones to Watch." We are proud to showcase rising talent in the field. Congratulations to all our 2020 honorees! #SNMMI #SNMMIOnestoWatch2020

4

6

41

SNMMI

@SNM_MI

3 years

SNMMI is pleased to announce our annual list of 30 early career professionals selected as “Ones to Watch” in 2021. Congratulations to the following honorees!

8

13

41

SNMMI

@SNM_MI

6 years

Nuclear medicine is a race against time. From the moment a medical radioisotope is generated, it starts to decay. It has been facing another ticking clock: a race against time to shore up the creaking medical radioisotope supply. Read more:

2

25

41

SNMMI

@SNM_MI

6 years

Technetium-99m is responsible for 80 percent of the nuclear medical imaging procedures performed in the world. This year marks its 60th anniversary, and Brookhaven National Laboratories is celebrating.

0

23

39

SNMMI

@SNM_MI

3 years

A new radionuclide therapy has been identified for HER2-positive breast cancer patients, according to research published in The Journal of Nuclear Medicine. #MedicalResearch #Theranostics #BreastCancer #JNM

1

18

40

SNMMI

@SNM_MI

4 years

Happy #NuclearMedicineAndMolecularImagingWeek - We'd like to thank you for your continued commitment to the field and your efforts to help transform medicine and improve lives. Learn more at - and be sure to share how you're celebrating using #NMW2020

0

22

41

SNMMI

@SNM_MI

4 months

According to new research published in @JournalofNucMed , a novel PET tracer enhances lesion detection in medullary thyroid cancer and offers the potential for targeted therapy. #NuclearMedicine #ThyroidCancer #MedicalImaging

0

14

40

SNMMI

@SNM_MI

7 years

Welcome to #SNMMI17 !

0

14

40

SNMMI

@SNM_MI

11 months

#SNMMI23 Abstract Highlight: FAPI PET imaging accurately assesses disease activity in rheumatoid #arthritis . #NuclearMedicine #PETscan

0

12

40

SNMMI

@SNM_MI

9 months

A new consensus recommendation for PET/MRI in oncologic imaging in adults has been released by SNMMI, EANM, and ISMRM. #NuclearMedicine #PETscan

1

14

39

SNMMI

@SNM_MI

1 year

PSMA PET/MRI accurately predicts risk of #ProstateCancer recurrence, according to a new study published in @JournalofNucMed . #NuclearMedicine #PETscan #JNuclMed

0

12

39

SNMMI

@SNM_MI

1 year

Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy, according to a new study in @JournalofNucMed #NuclearMedicine #RPTherapy #ProstateCancer #JNuclMed

0

14

37

SNMMI

@SNM_MI

3 years

Happy World Theranostics Day 2021! Get the latest radiopharmaceutical therapy updates from SNMMI and around the world, including recent articles from The Journal of Nuclear Medicine (JNM), at

0

18

39

SNMMI

@SNM_MI

2 months

8 million people every year use #nuclearmedicine to screen for and diagnose #heartdisease to avoid more expensive or invasive procedures. Dr. Dilsizian, Chief of Nuclear Medicine at the @UofMaryland , tells us more on @fox5dc :

3

10

38

SNMMI

@SNM_MI

3 years

Expanded PET imaging time window adds convenience and flexibility for neuroendocrine tumor patients, according to new research published in The Journal of Nuclear Medicine. #MedicalResearch #PETCT #NeuroendocrineCancer #JNM

0

14

38

SNMMI

@SNM_MI

6 months

Happy International Day of Medical Physics! On this day in 1867, Marie Curie, renowned for her groundbreaking research on radioactivity, was born in Poland. Today, we honor the essential role of medical physicists in improving patient care. ‘Standing on the Shoulders of Giants’

0

13

38

SNMMI

@SNM_MI

5 years

A 12-year study of patients who received peptide receptor radionuclide therapy for malignant neuroendocrine tumors shows its long-term effectiveness, which also allows patients to maintain a high quality of life. #NETCancer #PrecisionMedicine #PRRT

0

15

36

SNMMI

@SNM_MI

3 months

The Journal of Nuclear Medicine outlines the future of #theranostics in #neurooncology : #NuclearMedicine @JournalofNucMed

0

13

37

SNMMI

@SNM_MI

5 years

A new nuclear medicine tracer may allow better diagnosis of acute venous thromboembolism (VTE). Acute VTE is a disease that includes deep-vein thrombosis and its complication, pulmonary embolism, which can be fatal. #NuclearMedicine #DVT #VTE

6

24

33

SNMMI

@SNM_MI

3 years

With an increase of 27%, The Journal of Nuclear Medicine has again achieved the highest impact factor ever in its history, ranking third among all medical journals worldwide. #JNM #NuclearMedicine #MedicalImaging

0

6

36

SNMMI

@SNM_MI

4 years

The SNMMI Therapy Center of Excellence has designated March 31st as World Theranostics Day in honor of Dr. Saul Hertz, who conceived, developed, and administered the first radioiodine therapy to a patient on March 31st, 1941. #SNMMI #WorldTheranosticsDay #Theranostics

0

15

37

SNMMI

@SNM_MI

2 years

Thanks for a great #SNMMI22 Annual Meeting. We can’t wait to see you next year for the 2023 Annual Meeting in Chicago!

0

6

37

SNMMI

@SNM_MI

4 years

The virtual event of the summer begins today! It's time to join close to 8,000 participants this July 11-14 at the SNMMI Annual Meeting – Virtual Edition. Visit beginning at 11:00 am ET today! #SNMMIVirtual20

1

13

36

SNMMI

@SNM_MI

6 years

#SNMMI18 - Simon R. Cherry, PhD, Distinguished Professor at the University of California, Davis, received the prestigious Paul C. Aebersold Award and announced the completion of the first total body PET scanner.

0

20

37

SNMMI

@SNM_MI

11 months

Congratulations to Neeta Pandit-Taskar, MD, and colleagues for submitting the #SNMMI23 Abstract of the Year.

0

3

36

SNMMI

@SNM_MI

2 years

Congratulations to JNM’s Best Clinical Article Award recipients, Manuel Röhrich and colleagues, for their paper “Impact of 68Ga-FAPI PET/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas.” #SNMMI22 #JNM

0

12

36

SNMMI

@SNM_MI

3 years

A new treatment for late-stage #NeuroendocrineTumors has been found to be more effective and have fewer side effects than the current standard of care, according to new research in The Journal of Nuclear Medicine. #MedicalResearch #PRRT #NETCancer #JNM

0

14

35

SNMMI

@SNM_MI

11 months

Congratulations to the first annual Minoshima-Pappas Transformational Leadership Award winner, Umar Mahmood, MD, PhD. #NuclearMedicine #SNMMI23

0

5

35

SNMMI

@SNM_MI

2 years

SNMMI President-Elect Munir Ghesani, MD, was interviewed yesterday by DC FOX5 Morning about an unusual imaging pattern on FDG PET/CT scans that may be due to COVID-19 infection.

1

12

35

SNMMI

@SNM_MI

3 years

The U.S. Food and Drug Administration has approved Ga-68 PSMA-11 for PET imaging of PSMA-positive lesions in men with prostate cancer. It is the first approval for a PSMA PET tracer in the United States. #ProstateCancer #NuclearMedicine #PrecisionMedicine

0

14

35

SNMMI

@SNM_MI

1 year

SNMMI and @officialEANM have issued a new procedure standard/practice guideline for somatostatin receptor PET imaging for patients with #NeuroendocrineTumors : #NuclearMedicine #PETscan #JNuclMed #EANM

0

14

35

SNMMI

@SNM_MI

3 years

Congrats to Irène Buvat, PhD, recipient of the 2021 Hal Anger Lectureship Award. Dr. Buvat presented the Hal Anger Lectureship on “The Transformative Power of Artificial Intelligence in the Practice of Nuclear Medicine” during a special plenary session this morning. #SNMMI21

1

11

34

SNMMI

@SNM_MI

2 years

Happy Nuclear Medicine & Molecular Imaging Week—the time to celebrate you & your colleagues! Thank you for all you do to advance precision medicine & elevate the profession. Tell us how you’re celebrating. Be sure to tag #NucMed22 & #SNMMI in your posts!

0

16

34

SNMMI

@SNM_MI

3 years

PSMA PET/CT is more accurate than conventional CT in the detection of hepatocellular carcinoma metastases, according to research published in The Journal of Nuclear Medicine. #PersonalizedMedicine #PETimaging #PSMA #LiverCancer #JNM

1

18

34

SNMMI

@SNM_MI

3 years

Molecular imaging improves staging and treatment of pancreatic ductal adenocarcinomas, according to research in @JournalofNucMed . #MedicalImaging #PETCT #Cancer #PancreaticCancer #JNM

0

15

34

SNMMI

@SNM_MI

11 months

The SNMMI Mars Shot Research Fund is excited to announce 5 awardees for 2023, its inaugural year: Amir Iravani, MD, Paul Ellison, PhD, Craig Levin, PhD, Julie Sutcliffe, PhD, and Randy Yeh, MD. Congratulations! More at #SNMMI #MarsShotFund #NuclearMedicine

2

5

34

SNMMI

@SNM_MI

4 years

The novel radiopharmaceutical 18F-PSMA-1007 is effective and readily available for detecting malignant prostate cancer lesions, according to research published in The Journal of Nuclear Medicine. #ProstateCancer #PrecisionMedicine #NuclearMedicine #JNM

0

24

33

SNMMI

@SNM_MI

2 years

You asked, we delivered! In this new episode of the #SNMMI Podcast Series, Simon Cherry, PhD, discusses his recent 2022 Annual Meeting Cassen Award Lecture and more in a wide-ranging conversation with SNMMI President, Munir Ghesani, MD. Listen now at

1

11

33

SNMMI

@SNM_MI

2 years

A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre-treated metastatic castration-resistant #ProstateCancer , according to new research in The Journal of Nuclear Medicine. #PrecisionMedicine #NucMed #JNM

0

19

33

SNMMI

@SNM_MI

1 year

A novel PET agent effectively detects multiple cancers and identifies patients for targeted therapies, according to new research published in @JournalofNucMed #MedicalImaging #PETscan #Cancer #JNuclMed

0

10

32

SNMMI

@SNM_MI

1 year

A new treatment for Alzheimer’s disease, lecanemab, was approved today by the FDA. It has been shown to slow disease progression for early-stage patients. The presence of beta amyloid must be confirmed before treatment. #NuclearMedicine #PETscan #Alzheimer

1

18

33

SNMMI

@SNM_MI

3 years

SNMMI is pleased to announce its leadership team for 2021-22: Richard L. Wahl, MD, as president; and Munir Ghesani, MD, FACNM, FACR, as president-elect and Helen Nadel, MD, FRCPC, as vice president-elect. #SNMMI21

2

3

33

SNMMI

@SNM_MI

8 months

JNM has published an SNMMI consensus statement on patient selection and appropriate use of ¹⁷⁷Lu-PSMA-617 radionuclide therapy. Read more about it here: #NuclearMedicine #ProstateCancer #RPTherapy @JournalofNucMed

1

13

33

SNMMI

@SNM_MI

6 months

Novel PET radiotracer facilitates early, noninvasive detection of inflammatory bowel disease, according to new research published in @JournalofNucMed . #NuclearMedicine #IBD #MedicalImaging

0

11

31

SNMMI

@SNM_MI

4 years

The Journal of Nuclear Medicine has achieved the highest impact factor in its 6o-year history, ranking fourth among all medical journals worldwide, according to the 2019 Journal Citation Reports. #JNM #NuclearMedicine #MedicalResearch

0

8

31

SNMMI

@SNM_MI

2 months

A new PET radiotracer can differentiate diseased tissues from healthy tissues based on fructose metabolism, according to new research published in the March issue of @JournalofNucMed . #NuclearMedicine #Metabolism #MedicalImaging

0

10

32

SNMMI

@SNM_MI

2 years

Appropriate use criteria for prostate-specific membrane antigen PET imaging published in The Journal of Nuclear Medicine. #PrecisionMedicine #PETimaging #ProstateCancer #PSMA #JNM

0

11

32

SNMMI

@SNM_MI

7 months

On behalf of SNMMI & SNMMI-TS Leadership, we're thrilled to celebrate Nuclear Medicine & Molecular Imaging Week with you! Let's kick off Nuclear Medicine Week in style! Share your celebrations with us using #NMW23 and enter our giveaway for a chance to win awesome SNMMI NMW swag!

1

14

31

SNMMI

@SNM_MI

3 years

A new set of appropriate use criteria is now available for prostate-specific membrane antigen (PSMA) PET imaging to detect prostate cancer—developed by SNMMI in collaboration with four peer societies. #NuclearMedicine #ProstateCancer #MedicalImaging

0

12

30

SNMMI

@SNM_MI

3 years

Phase 3 Trial of 177Lu-PSMA-617 Meets Survival End Points via @CancerNetwrk

Phase 3 Trial of 177Lu-PSMA-617 Meets Survival End Points

Novartis announced that its investigational targeted radioligand therapy 177Lu-PSMA-617 demonstrated statistically significant improvements in overall and radiographic progression-free survival...

www.cancernetwork.com

0

8

31

SNMMI

@SNM_MI

4 months

PET imaging with ⁶⁸Ga-FAPI can more effectively detect and stage pancreatic cancer compared with ¹⁸F-FDG imaging or contrast-enhanced CT, according to research from @JournalofNucMed . Read more: #NuclearMedicine #PancreaticCancer #MolecularImaging

0

15

31

SNMMI

@SNM_MI

11 months

Paul Ellison, PhD, Univ of Wisconsin, and Peter Scott, PhD, and Melanie Sanford, PhD, Univ of Michigan, have received a grant from the 2023 SNMMI Mars Shot Fund. Congratulations! @wiscmedphys @Scott_LabUM @Sanford_Lab @MichiganChem @UMichRadiology

1

7

31

SNMMI

@SNM_MI

2 years

Novel radioligand therapy proven superior for metastatic prostate cancer patients, according to The Journal of Nuclear Medicine. #PresicionMedicine #NuclearMedicine #ProstateCancer #JNM

0

9

31

SNMMI

@SNM_MI

1 year

A new study in @JournalofNucMed has determined that approximately three percent of all #BoneScan patients have markers of #CardiacAmyloidosis , which can lead to heart failure and increased mortality. #NuclearMedicine #MedicalResearch #JNuclMed

0

14

30

SNMMI

@SNM_MI

4 months

JNM research highlight: New PET tracer noninvasively identifies cancer gene mutation, allowing for more precise diagnosis and therapy. #NuclearMedicine #PETscan #Cancer @JournalofNucMed

0

11

31

SNMMI

@SNM_MI

11 months

#SNMMI23 Abstract Highlight: Personalized dosing in #ProstateCancer treatment improves patient outcomes. #NuclearMedicine #Dosimetry

0

8

31